{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:09:58Z","timestamp":1790604598610,"version":"4.1.0"},"reference-count":62,"publisher":"American Chemical Society (ACS)","issue":"38","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010666","name":"H2020 Research Infrastructures","doi-asserted-by":"publisher","award":["GA 101008571"],"award-info":[{"award-number":["GA 101008571"]}],"id":[{"id":"10.13039\/100010666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Identifying suitable chelators for 212Pb, 223Ra, and 225Ac and their diagnostic counterparts 131Ba, 133La, and 203Pb remains one of the major challenges in the development of radiopharmaceuticals for targeted alpha therapy. Four novel macrocyclic chelators containing the 2,4- and 2,6-pyrimidine moieties (pym-2,4 and pym-2,6), along with a combination thereof (pym-mix), as well as the pyrazine moiety (pazi), were synthesized and fully characterized. Protonation constants (pKa) were determined using 1H NMR spectroscopy. Stability constants (log K) for the complexes with La3+ (11.8\u201312.6), Ba2+ (10.1\u201310.3), and Pb2+ (15.3\u201315.5) are lower compared to macropa. However, pH-dependent binding affinities (pKd,M) with the novel chelators are higher for Ba2+ (8.7\u20138.9) and comparable or slightly lower for La3+ and Pb2+ at pH 6. DFT calculations enabled comprehensive elucidation of the molecular structures, facilitating in-depth analyses of the coordination environment. The determined 15N NMR chemical shifts of free chelators and complexes help to explain distinct complexation behavior. Finally, the novel chelators were radiolabeled with 131Ba, 223Ra, 133La, 225Ac, 203Pb, and 212Pb, and the radiochemical conversions were compared to results with macropa. All 223Ra complexes were incubated in human serum, pointing out an increased kinetic inertness and stability.<\/jats:p>","DOI":"10.1021\/acs.inorgchem.6c01646","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:01:58Z","timestamp":1789560118000},"page":"22246-22260","source":"Crossref","is-referenced-by-count":0,"title":["The Second\nNitrogen Fits: Development of Diazine-Based\nMacrocyclic Chelators to Stably Bind Radionuclides Used in Targeted\nAlpha Therapy"],"prefix":"10.1021","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1358-3560","authenticated-orcid":true,"given":"Magdalena K.","family":"Blei","sequence":"first","affiliation":[{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-01328"]},{"name":"TU Dresden , , ,","place":["Dresden, Germany, D-01062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Waurick","sequence":"additional","affiliation":[{"name":"TU Dresden , , ,","place":["Dresden, Germany, D-01062"]},{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-0132"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-0466","authenticated-orcid":true,"given":"Bjo\u0308rn","family":"Drobot","sequence":"additional","affiliation":[{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-0132"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7840-6858","authenticated-orcid":true,"given":"Santiago A.","family":"Bru\u0308hlmann","sequence":"additional","affiliation":[{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-01328"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Duchemin","sequence":"additional","affiliation":[{"name":"CERN, The European Organization for Nuclear Research , ,","place":["Geneva, Switzerland, CH-1211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgars","family":"Mamis","sequence":"additional","affiliation":[{"name":"CERN, The European Organization for Nuclear Research , ,","place":["Geneva, Switzerland, CH-1211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Inzamam","sequence":"additional","affiliation":[{"name":"CERN, The European Organization for Nuclear Research , ,","place":["Geneva, Switzerland, CH-1211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Stora","sequence":"additional","affiliation":[{"name":"CERN, The European Organization for Nuclear Research , ,","place":["Geneva, Switzerland, CH-1211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Audouin","sequence":"additional","affiliation":[{"name":"GIP ARRONAX , 1 Rue Aronnax , ,","place":["Saint-Herblain, France, 44800"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sounalet","sequence":"additional","affiliation":[{"name":"IMT Atlantique, CNRS\/IN2P3, Nantes Universite\u0301 , , ,","place":["Nantes, France, 44307"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-1271","authenticated-orcid":true,"given":"Klaus","family":"Kopka","sequence":"additional","affiliation":[{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-01328"]},{"name":"TU Dresden , , ,","place":["Dresden, Germany, D-01062"]},{"name":"National Center for Tumor Diseases (NCT) , , ,","place":["Dresden, Germany, D-01307"]},{"name":"German Cancer Consortium (DKTK) , , Fetscherstr. 74 , ,","place":["Dresden, Germany, D-01307"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Stumpf","sequence":"additional","affiliation":[{"name":"TU Dresden , , ,","place":["Dresden, Germany, D-01062"]},{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-0132"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-5330","authenticated-orcid":true,"given":"Sven","family":"Stadlbauer","sequence":"additional","affiliation":[{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-01328"]},{"name":"TU Dresden , , ,","place":["Dresden, Germany, D-01062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-8134","authenticated-orcid":true,"given":"Jerome","family":"Kretzschmar","sequence":"additional","affiliation":[{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-0132"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1906-3186","authenticated-orcid":true,"given":"Constantin","family":"Mamat","sequence":"additional","affiliation":[{"name":"Helmholtz-Zentrum Dresden-Rossendorf , , Bautzner Landstr. 400 , ,","place":["Dresden, Germany, D-01328"]},{"name":"TU Dresden , , ,","place":["Dresden, Germany, D-01062"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"1","key":"2026092809221517800_cit1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals\nand their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduction\nTargeted Ther."},{"key":"2026092809221517800_cit2","doi-asserted-by":"publisher","first-page":"20170969","DOI":"10.1259\/bjr.20170969","article-title":"Theranostic\nradiopharmaceuticals: established agents in current use","volume":"91","author":"Ballinger","year":"2018","journal-title":"Br. J. Radiol."},{"issue":"4","key":"2026092809221517800_cit3","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.220157","article-title":"A Review of Theranostics: Perspectives on Emerging\nApproaches and Clinical Advancements","volume":"5","author":"Burkett","year":"2023","journal-title":"Radiol.\nImaging Cancer"},{"key":"2026092809221517800_cit4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical\nTherapy in Cancer: Clinical Advances and Challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026092809221517800_cit5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/ph17010076","article-title":"Alpha-Emitting Radionuclides: Current Status and Future\nPerspectives","volume":"17","author":"Miederer","year":"2024","journal-title":"Pharmaceuticals"},{"key":"2026092809221517800_cit6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1039\/9781837677139-00111","article-title":"Chelator Design\nand Radiolabeling Chemistry of Radiometals","volume-title":"Targeted Radiopharmaceuticals and Imaging:development Challenges\nand Opportunitiesed","author":"Krol","year":"2025"},{"key":"2026092809221517800_cit7","doi-asserted-by":"publisher","first-page":"12030","DOI":"10.1021\/acs.chemrev.5c00641","article-title":"Chemical Tools to Characterize the Coordination Chemistry\nof Radionuclides for Radiopharmaceutical Applications","volume":"125","author":"Boros","year":"2025","journal-title":"Chem. Rev."},{"key":"2026092809221517800_cit8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3390\/ph16101460","article-title":"Radiometals in Imaging\nand Therapy: Highlighting Two\nDecades of Research","volume":"16","author":"Sharma","year":"2023","journal-title":"Pharmaceuticals"},{"key":"2026092809221517800_cit9","doi-asserted-by":"publisher","first-page":"109027","DOI":"10.1016\/j.nucmedbio.2025.109027","article-title":"Potent candidates\nfor Targeted Alpha Therapy (TAT","volume":"146-147","author":"Filosofov","year":"2025","journal-title":"Nucl. Med.\nBiol."},{"issue":"5","key":"2026092809221517800_cit10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00259-024-06658-1","article-title":"Advances in\ntargeted alpha therapy of cancer","volume":"51","author":"Sathekge","year":"2024","journal-title":"Eur. J. Nucl.\nMed. Mol. Imaging"},{"key":"2026092809221517800_cit11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1874471011666180426130058","article-title":"Dosimetry\nand Radiobiology of Alpha-Particle\nEmitting Radionuclides","volume":"11","author":"Sgouros","year":"2018","journal-title":"Curr. Radiopharm."},{"key":"2026092809221517800_cit12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1158\/1078-0432.CCR-12-0298","article-title":"Molecular\npathways: targeted \u03b1-particle\nradiation therapy","volume":"19","author":"Baidoo","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"2026092809221517800_cit13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/pharmaceutics13060906","article-title":"Overview of the\nMost Promising Radionuclides for Targeted\nAlpha Therapy: The \u201cHopeful Eight","volume":"13","author":"Eychenne","year":"2021","journal-title":"Pharmaceutics"},{"key":"2026092809221517800_cit14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.brachy.2023.06.228","article-title":"Actinium-225\nTargeted Agents: Where Are We Now?","volume":"22","author":"Mourtada","year":"2023","journal-title":"Brachytherapy"},{"key":"2026092809221517800_cit15","doi-asserted-by":"publisher","first-page":"14712","DOI":"10.1002\/anie.201709532","article-title":"An Eighteen-Membered Macrocyclic Ligand for Actinium-225\nTargeted Alpha Therapy","volume":"56","author":"Thiele","year":"2017","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026092809221517800_cit16","doi-asserted-by":"publisher","first-page":"7203","DOI":"10.7150\/thno.78043","article-title":"Modulating\nthe pharmacokinetic profile of Actinium-225-labeled macropa-derived\nradioconjugates by dual targeting of PSMA and albumin","volume":"12","author":"Reissig","year":"2022","journal-title":"Theranostics"},{"key":"2026092809221517800_cit17","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1158\/1078-0432.CCR-23-3746","article-title":"Preclinical\nEfficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer","volume":"30","author":"Schatz","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"2026092809221517800_cit18","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/cancers13081974","article-title":"Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild\nCondition Radiolabeling and Targeting PSMA\u2500A Proof of Concept\nStudy","volume":"13","author":"Reissig","year":"2021","journal-title":"Cancers"},{"key":"2026092809221517800_cit19","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/ph16111622","article-title":"Theranostic Imaging\nSurrogates for Targeted Alpha Therapy: Progress in Production, Purification,\nand Applications","volume":"16","author":"Nelson","year":"2023","journal-title":"Pharmaceuticals"},{"key":"2026092809221517800_cit20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2967\/jnumed.121.262459","article-title":"First In Vivo and Phantom Imaging of Cyclotron-Produced\n            133La as a Theranostic Radionuclide for\n              225Ac and\n              135La","volume":"63","author":"Nelson","year":"2022","journal-title":"J. Nucl.\nMed."},{"key":"2026092809221517800_cit21","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/ph15101167","article-title":"Efficient\nProduction of the PET Radionuclide 133La for Theranostic\nPurposes in Targeted Alpha Therapy Using\nthe 134Ba(p,2n)133La Reaction","volume":"15","author":"Bru\u0308hlmann","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"2026092809221517800_cit22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s41181-024-00292-w","article-title":"Scalability study on [133La]LaCl3 production with a focus on potential clinical\napplications","volume":"9","author":"Bru\u0308hlmann","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"issue":"1","key":"2026092809221517800_cit23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41181-025-00362-7","article-title":"212Pb\nin targeted radionuclide therapy:\na review","volume":"10","author":"Scaffidi-Muta","year":"2025","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"2026092809221517800_cit24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.nucmedbio.2022.06.002","article-title":"Bismuth chelation for\ntargeted alpha\ntherapy: Current state of the art","volume":"114-115","author":"Franchi","year":"2022","journal-title":"Nucl. Med.\nBiol."},{"issue":"1","key":"2026092809221517800_cit25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40658-025-00763-2","article-title":"Gamma camera imaging\ncharacteristics of 203\/212Pb as a theragnostic pair for\ntargeted alpha therapy: a feasibility study","volume":"12","author":"Ka\u0308stner","year":"2025","journal-title":"EJNMMI Phys."},{"issue":"239","key":"2026092809221517800_cit26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0020-1693(95)04708-5","article-title":"Lead (II)\nComplexes of 1,4,7,10-Tetraazacyclodode cane-N,N\u2019,N\u2019\u2019,N\u2019\u2019\u2019-Tetraacetate:\nSolution Chemistry and Application to Tumor Localization with 203Pb Labeled Monoclonal Antibodies","volume":"239","author":"Pippin","year":"1995","journal-title":"Inorg. Chim. Acta"},{"key":"2026092809221517800_cit27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0360-3016(95)02119-1","article-title":"The Use of 212Pb-Labeled Monoclonal Antibody\nin the Treatment of Murine Erythroleukemia","volume":"34","author":"Ruble","year":"1996","journal-title":"Int. J. Radiat Oncol."},{"key":"2026092809221517800_cit28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1524\/ract.1993.60.1.1","article-title":"The Chemical Fate of 212Bi-DOTA Formed by \u03b2\u2013 Decay of 212Pb(DOTA)2\u2013","volume":"60","author":"Mirzadeh","year":"1993","journal-title":"Radiochim. Acta"},{"key":"2026092809221517800_cit29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0969-8051(99)00086-4","article-title":"Characterization,\nand Evaluation\nof a Novel Bifunctional Chelating Agent for the Lead Isotopes 203Pb and 212Pb","volume":"27","author":"Chappell","year":"2000","journal-title":"Nucl. Med.\nBiol."},{"key":"2026092809221517800_cit30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/pharmaceutics15020414","article-title":"Preclinical\nEvaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides\nfor 203Pb and 212Pb-Based Theranostics","volume":"15","author":"Li","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"2026092809221517800_cit31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41181-021-00121-4","article-title":"Production, Purification, and Radiolabeling\nof the 203Pb\/212Pb Theranostic Pair","volume":"6","author":"McNeil","year":"2021","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"2026092809221517800_cit32","doi-asserted-by":"publisher","first-page":"20699","DOI":"10.1021\/acs.inorgchem.3c01983","article-title":"Equilibrium Thermodynamics\nof Macropa Complexes with Selected Metal Isotopes of Radiopharmaceutical\nInterest","volume":"62","author":"Blei","year":"2023","journal-title":"Inorg. Chem."},{"key":"2026092809221517800_cit33","doi-asserted-by":"publisher","first-page":"22422","DOI":"10.1021\/acs.inorgchem.5c03908","article-title":"Heavy Alkaline\nEarth Radiometals for Cancer Theranostics: Coordination and Radiochemistry\nof Radium-223 and Barium-131 with Kryptofix 22-Based Chelators","volume":"64","author":"Franchi","year":"2025","journal-title":"Inorg. Chem."},{"key":"2026092809221517800_cit34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1515\/chem-2016-0011","article-title":"The Radiochemical and Radiopharmaceutical\nApplications of Radium","volume":"14","author":"Gott","year":"2016","journal-title":"Open Chem."},{"issue":"1","key":"2026092809221517800_cit35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s41181-023-00220-4","article-title":"The Curies\u2019\nelement: state of the art and perspectives on the use of radium in\nnuclear medicine","volume":"8","author":"Franchi","year":"2023","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"2026092809221517800_cit36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1515\/ract-2021-1141","article-title":"The aqueous\nchemistry of radium","volume":"110","author":"Brown","year":"2022","journal-title":"Radiochim. Acta"},{"key":"2026092809221517800_cit37","doi-asserted-by":"publisher","first-page":"9938","DOI":"10.1039\/D2CC03156F","article-title":"Elucidating\nthe Coordination chemistry\nof the radium ion for targeted alpha therapy","volume":"58","author":"Ivanov","year":"2022","journal-title":"Chem. Commun."},{"issue":"1","key":"2026092809221517800_cit38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/pharmaceutics13010049","article-title":"Targeted alpha therapy: progress\nin radionuclide production, radiochemistry, and applications","volume":"13","author":"Nelson","year":"2020","journal-title":"Pharmaceutics"},{"key":"2026092809221517800_cit39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/ph13100272","article-title":"Recent Insights\nin Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production,\nSeparation, Radiolabeling, and Imaging","volume":"13","author":"Reissig","year":"2020","journal-title":"Pharmaceuticals"},{"key":"2026092809221517800_cit40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nucmedbio.2021.05.003","article-title":"The impact\nof barium isotopes in\nradiopharmacy and nuclear medicine \u2013 From past to presence","volume":"98","author":"Reissig","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"2026092809221517800_cit41","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s10953-017-0679-7","article-title":"Barium and radium complexation\nwith ethylenediamine etetraacetic acid in aqueous alkaline sodium\nchloride media","volume":"46","author":"Matyskin","year":"2017","journal-title":"J. Solution Chem."},{"key":"2026092809221517800_cit42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0048-9697(87)90127-6","article-title":"Critical stability\nconstants, enthalpies and entropies\nfor the formation of metal complexes of aminopolycarboxylic acids\nand carboxylic acids","volume":"64","author":"Smith","year":"1987","journal-title":"Sci. Total Environ."},{"key":"2026092809221517800_cit43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/10610279608032555","article-title":"Stability\nconstants of metal complexes of macrocyclic ligands with\npendant donor groups","volume":"6","author":"Martell","year":"1996","journal-title":"Supramol. Chem."},{"key":"2026092809221517800_cit44","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1021\/ic990135+","article-title":"Ionizable Calixarene-Crown Ethers\nwith High Selectivity for Radium over Light Alkaline Earth Metal Ions","volume":"38","author":"Chen","year":"1999","journal-title":"Inorg. Chem."},{"issue":"6","key":"2026092809221517800_cit45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/open.201800019","article-title":"Modified Calix[4]crowns\nas Molecular\nReceptors for Barium","volume":"7","author":"Steinberg","year":"2018","journal-title":"ChemistryOpen"},{"key":"2026092809221517800_cit46","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1039\/D2QI01637K","article-title":"Calix[4]crowns with\nperfluoroalkylsulfonylcarboxamide functions: a complexation approach\nfor heavy group 2 metal ions","volume":"10","author":"Reissig","year":"2023","journal-title":"Inorg. Chem. Front."},{"key":"2026092809221517800_cit47","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1021\/ja00856a018","article-title":"2]-Cryptates: stability\nand selectivity of alkali and\nalkaline-earth macrobicyclic complexes","volume":"97","author":"Lehn","year":"1975","journal-title":"J. Am.\nChem. Soc."},{"key":"2026092809221517800_cit48","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/hlca.19750580427","article-title":"Thermodynamik\nder Metallkomplexbildung mit Polyoxadiazamacrocyclen","volume":"58","author":"Anderegg","year":"1975","journal-title":"Helv. Chim. Acta"},{"key":"2026092809221517800_cit49","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1021\/jacs.8b08704","article-title":"Rapid Dissolution of BaSO4 by Macropa, an 18-Membered Macrocycle with High Affinity for Ba2+","volume":"140","author":"Thiele","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"2026092809221517800_cit50","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1039\/D0SC06867E","article-title":"Towards the stable chelation of radium for biomedical\napplications with an 18-membered macrocyclic ligand","volume":"12","author":"Abou","year":"2021","journal-title":"Chem. Sci."},{"key":"2026092809221517800_cit51","doi-asserted-by":"publisher","first-page":"20834","DOI":"10.1021\/acs.inorgchem.3c02985","article-title":"Reining in Radium\nfor Nuclear Medicine: Extra-Large Chelator Development for an Extra-Large\nIon","volume":"62","author":"Simms","year":"2023","journal-title":"Inorg. Chem."},{"issue":"3","key":"2026092809221517800_cit52","doi-asserted-by":"publisher","DOI":"10.1002\/jlcr.4136","article-title":"Preparation\nof Macrobicyclic Cryptands for Radiometal Complexation","volume":"68","author":"Ho\u0308ffmann","year":"2025","journal-title":"J. Label. Compd. Radiopharm."},{"key":"2026092809221517800_cit53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1039\/f19878300339","article-title":"The thermodynamics\nof solvation of ions. Part 2.\u2500The enthalpy of hydration at\n298.15 K","volume":"83","author":"Marcus","year":"1987","journal-title":"J. Chem. Soc., Faraday Trans. 1"},{"key":"2026092809221517800_cit54","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.3390\/molecules28124881","article-title":"Eu(III) and\nCm(III) Complexation by the Aminocarboxylates NTA, EDTA, and EGTA\nStudied with NMR, TRLFS, and ITC - An Improved Approach to More Robust\nThermodynamics","volume":"28","author":"Friedrich","year":"2023","journal-title":"Molecules"},{"key":"2026092809221517800_cit55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0040-4020(01)97695-1","article-title":"Darstellung und Komplexbildung\nvon\nPolyazacycloalkan-N-Essigsa\u0308uren","volume":"37","author":"Stetter","year":"1981","journal-title":"Tetrahedron"},{"key":"2026092809221517800_cit56","volume-title":"Nuclear and Radiochemistry:\nFundamentals and Applications","author":"Kratz","year":"2022","edition":"4th"},{"key":"2026092809221517800_cit57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.saa.2018.03.029","article-title":"Chelation of heavy\ngroup 2 (radio)metals by p-tert-butylcalix[4]arene-1,3-crown-6 and\nlogK determination via NMR","volume":"199","author":"Bauer","year":"2018","journal-title":"Spectrochim. Acta,\nPart A"},{"issue":"9","key":"2026092809221517800_cit58","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1021\/ja808534w","article-title":"Macrocyclic\nReceptor Exhibiting Unprecedented Selectivity for Light Lanthanides","volume":"131","author":"Roca-Sabio","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"2026092809221517800_cit59","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1021\/ic200182e","article-title":"Macrocyclic Receptor Showing Extremely\nHigh Sr(II)\/Ca(II) and Pb(II)\/Ca(II) Selectivities with Potential\nApplication in Chelation Treatment of Metal Intoxication","volume":"50","author":"Ferreiro\u0301s-Marti\u0301nez","year":"2011","journal-title":"Inorg. Chem."},{"key":"2026092809221517800_cit60","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1107\/S0567739476001551","article-title":"Revised\neffective ionic radii and systematic studies of interatomic distances\nin halides and chalcogenides","volume":"A32","author":"Shannon","year":"1976","journal-title":"Acta Crystallogr."},{"key":"2026092809221517800_cit61","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1021\/ed045p581","article-title":"Hard and\nsoft acids and bases, HSAB, part 1: Fundamental principles","volume":"45","author":"Pearson","year":"1968","journal-title":"J. Chem. Educ."},{"key":"2026092809221517800_cit62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1351\/pac196408030243","article-title":"Solvent isotope\neffect in H2O\u2013D2O mixtures","volume":"8","author":"Kresge","year":"1964","journal-title":"Pure Appl. Chem."}],"container-title":["Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.inorgchem.6c01646","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/inocaj\/article-pdf\/65\/38\/22246\/68529071\/acs.inorgchem.6c01646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/inocaj\/article-pdf\/65\/38\/22246\/68529071\/acs.inorgchem.6c01646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:30:16Z","timestamp":1790602216000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/inocaj\/article\/65\/38\/22246\/5431118\/The-Second-Nitrogen-Fits-Development-of-Diazine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":62,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2026,9,16]]},"published-print":{"date-parts":[[2026,9,28]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.inorgchem.6c01646","relation":{},"ISSN":["0020-1669","1520-510X"],"issn-type":[{"value":"0020-1669","type":"print"},{"value":"1520-510X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}